Dupilumab Associated Head and Neck Dermatitis Resolves Temporarily with Itraconazole therapy, and Rapidly with Transition to Upadacitinib, with Malassezia-Specific IgE Levels Mirroring Clinical Response

Name: Dupilumab Associated Head and Neck Dermatitis Resolves Temporarily with Itraconazole therapy, and Rapidly with Transition to Upadacitinib, with Malassezia-Specific IgE Levels Mirroring Clinical Response
Creator: John Frew
Published: 2022-05-12T08:53:58.624Z
Keywords: Atopic Dermatitis

Frew, John

doi:10.17632/mz3n2gjjy3.1

Dupilumab Associated Head and Neck Dermatitis Resolves Temporarily with Itraconazole therapy, and Rapidly with Transition to Upadacitinib, with Malassezia-Specific IgE Levels Mirroring Clinical Response

Published: 12 May 2022| Version 1 | DOI: 10.17632/mz3n2gjjy3.1

Contributor:

John Frew

Description

Supplementary Material

Dupilumab Associated Head and Neck Dermatitis Resolves Temporarily with Itraconazole therapy, and Rapidly with Transition to Upadacitinib, with Malassezia-Specific IgE Levels Mirroring Clinical Response

Description

Files

Categories

Licence